期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 22, 页码 7323-7327出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm901191q
关键词
-
Death-associated protein kinases (DAPKs) function in the early stages of eukaryotic programmed cell death. DAPKs are now emerging as targets for drug discovery in novel therapeutic approaches for ischemic diseases in the brain, heart, kidney, and other organs. Using a structure-based virtual screening approach, we discovered potent and selective DAPKs inhibitors. 6 was found to be the most potent inhibitor with enzyme selectivity (IC50 = 69 nM for DAPK1).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据